Pfizer Establishes Innovation Tech Subsidiary in Hangzhou with $37.7 Million Registered Capital

Tianyancha App shows that on May 19, Pfizer (Hangzhou) Innovation Technology Co., Ltd. was established, with Jean-Christophe, Michel Pointeau as the legal representative. The registered capital is 37.6965 million US dollars, and the business scope includes technical services, software development, data processing services, software sales, health consulting services, etc. Shareholder information shows that the company is wholly owned by Pfizer Inc. of the United States.